ElectroCore Announces Issuance Of 2 U.S. Patents Entitled "Devices And Methods For Vagal Nerve Stimulation"; "Devices And Methods For Remote Therapy And Patient Monitoring"

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received two patent issue notifications from the United States Patent and Trademark Office (USPTO).

US Patent No. 12,208,263 entitled "Devices and Methods for Vagal Nerve Stimulation" was issued on January 28, 2025 and generally relates to methods for modulating the vagus nerve by positioning an electrode in contact with an electrically conductive gel on the neck of the user, delivering an electrical impulse to the vagus nerve and adjusting a position of the electrode on the neck based on a pressure sensation of the electrode against the neck.